Imetelstat therapy in refractory anemia with ring sideroblasts with or without thrombocytosis

Blood Cancer J. 2016 Mar 11;6(3):e405. doi: 10.1038/bcj.2016.13.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anemia, Refractory / complications*
  • Anemia, Refractory / diagnosis
  • Anemia, Refractory / drug therapy*
  • Anemia, Refractory / genetics
  • Anemia, Sideroblastic / complications*
  • Anemia, Sideroblastic / diagnosis
  • Anemia, Sideroblastic / drug therapy*
  • Anemia, Sideroblastic / genetics
  • Combined Modality Therapy
  • Humans
  • Indoles / therapeutic use*
  • Niacinamide / analogs & derivatives*
  • Niacinamide / therapeutic use
  • Oligonucleotides
  • Thrombocytosis / complications*
  • Thrombocytosis / diagnosis

Substances

  • Indoles
  • Oligonucleotides
  • Niacinamide
  • imetelstat